Health
Donor stem cell transplant can improve survival rates for older patients with MDS, study shows – News-Medical.Net
A new clinical trial offers the most compelling evidence to date that a donor stem cell transplant can improve survival rates for older patients with higher-risk…
A new clinical trial offers the most compelling evidence to date that a donor stem cell transplant can improve survival rates for older patients with higher-risk myelodysplastic syndrome (MDS), Dana-Farber Cancer Institute investigators report at the virtual 62nd American Society of Hematology (ASH) Annual Meeting.
Despite being the only current cure for MDS and widely used for younger patients, transplant generally hasn’t been offered to older patients because it has not been proven beneficial…
-
Noosa News21 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business20 hours agoDicker Data rides the AI trend to double digit growth
-
Business24 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy
-
Noosa News21 hours agoBob Katter threatens Channel 9 journalist for asking question on family heritage